Literature DB >> 27282423

Control of HPV-associated cancers with HPV vaccination.

Mark Schiffman1, Mona Saraiya2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27282423      PMCID： PMC6097619          DOI： 10.1016/S1473-3099(16)30146-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  11 in total

1.  Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia.

Authors:  Julia M L Brotherton; Shelley L Deeks; Sue Campbell-Lloyd; Avner Misrachi; Irene Passaris; Karen Peterson; Helen Pitcher; Megan Scully; Maureen Watson; Rosalind Webby
Journal:  Commun Dis Intell Q Rep       Date:  2008-12

2.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

Review 3.  The Australian experience with the human papillomavirus vaccine.

Authors:  Suzanne M Garland
Journal:  Clin Ther       Date:  2014-01-01       Impact factor: 3.393

Review 4.  Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging.

Authors:  Douglas R Lowy; Rolando Herrero; Allan Hildesheim
Journal:  Lancet Oncol       Date:  2015-05       Impact factor: 41.316

5.  Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

Authors:  Aimée R Kreimer; Frank Struyf; Maria Rowena Del Rosario-Raymundo; Allan Hildesheim; S Rachel Skinner; Sholom Wacholder; Suzanne M Garland; Rolando Herrero; Marie-Pierre David; Cosette M Wheeler; Paula González; Silvia Jiménez; Douglas R Lowy; Ligia A Pinto; Caroline Porras; Ana Cecilia Rodriguez; Mahboobeh Safaeian; Mark Schiffman; John T Schiller; John Schussler; Mark E Sherman; F Xavier Bosch; Xavier Castellsague; Archana Chatterjee; Song-Nan Chow; Dominique Descamps; Francisco Diaz-Mitoma; Gary Dubin; Maria Julieta Germar; Diane M Harper; David J M Lewis; Genara Limson; Paulo Naud; Klaus Peters; Willy A J Poppe; Brian Ramjattan; Barbara Romanowski; Jorge Salmeron; Tino F Schwarz; Julio C Teixeira; Wiebren A A Tjalma
Journal:  Lancet Oncol       Date:  2015-06-09       Impact factor: 41.316

6.  Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.

Authors:  Beatriz Serrano; Silvia de Sanjosé; Sara Tous; Beatriz Quiros; Nubia Muñoz; Xavier Bosch; Laia Alemany
Journal:  Eur J Cancer       Date:  2015-06-26       Impact factor: 9.162

Review 7.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 8.  HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

Authors:  F Xavier Bosch; Claudia Robles; Mireia Díaz; Marc Arbyn; Iacopo Baussano; Christine Clavel; Guglielmo Ronco; Joakim Dillner; Matti Lehtinen; Karl-Ulrich Petry; Mario Poljak; Susanne K Kjaer; Chris J L M Meijer; Suzanne M Garland; Jorge Salmerón; Xavier Castellsagué; Laia Bruni; Silvia de Sanjosé; Jack Cuzick
Journal:  Nat Rev Clin Oncol       Date:  2015-09-01       Impact factor: 66.675

9.  Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.

Authors:  Silvia Franceschi; M Chantal Umulisa; Ugyen Tshomo; Tarik Gheit; Iacopo Baussano; Vanessa Tenet; Tshokey Tshokey; Maurice Gatera; Fidele Ngabo; Pierre Van Damme; Peter J F Snijders; Massimo Tommasino; Alex Vorsters; Gary M Clifford
Journal:  Int J Cancer       Date:  2016-04-15       Impact factor: 7.396

10.  Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England.

Authors:  D Mesher; K Soldan; R Howell-Jones; K Panwar; P Manyenga; M Jit; S Beddows; O N Gill
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641
View more
  1 in total

1.  Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria.

Authors:  Nanma T Cosmas; Lohya Nimzing; Daniel Egah; Ayo Famooto; Sally N Adebamowo; Clement A Adebamowo
Journal:  BMC Infect Dis       Date:  2022-04-05       Impact factor: 3.090
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.